• Public single-cell RNA-seq data investigation using QIAGEN OmicSoft and Ingenuity Pathway Analysis

    Virtual - Americas - EST , United States

    Single-cell RNA-sequencing (scRNA-seq) is widely used to investigate tissue heterogeneity, identify novel cell types, study pathogenic mechanisms, develop targeted therapy (including immunotherapy) and more. Accordingly, a tremendous amount of scRNA-seq data has been deposited to public domains like GEO. In this training, you will learn how to · Locate public single-cell studies of interest using […]

  • Proteomics and phosphoproteomics data interpretation using QIAGEN Ingenuity Pathway Analysis

    Virtual - Americas - EST , United States

    In this live QIAGEN Ingenuity Pathway Analysis (IPA) training, we’ll focus on interpreting proteomics and phosphoproteomics datasets. In this tutorial, we’ll guide you through steps and workflows to address your questions related to interpreting proteomics and phosphoproteomics datasets using QIAGEN IPA, such as: • How should I format the data before uploading to IPA? • […]

  • How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting: Part 1

    We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18, 2023. The two-part, content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of […]

  • QIAGEN Ingenuity Pathway Analysis (IPA) for grant writing and publications with new features

    Virtual - Americas - EST , United States

    QIAGEN Ingenuity Pathway Analysis (IPA) represents a robust resource to aid in the process of writing grants publications. Driven by a wealth of manually-curated molecular interactions and associations in the QIAGEN Knowledge Base together with pre-analyzed public ‘omics data for hundreds of thousands of samples from QIAGEN OmicSoft Lands, IPA provides biological insights regardless of […]

  • Como anotar variantes somáticas e avaliar a prevalência delas com um único banco de dados

    Virtual - Portugal , Portugal

    Dentro das aplicações oncológicas, a habilidade de identificar alterações genéticas potencialmente acionáveis e explorar as vulnerabilidades moleculares do câncer está se tornando cada vez mais difícil. Um novo banco de dados desenvolvido pela QIAGEN, o HSMD, contém mais de 2 décadas de conteúdo com curadoria especializada e dados da QIAGEN Knowledge Base com mais de […]

  • Single-cell RNA-seq data analysis and interpretation

    Virtual - Americas - EST , United States

    Explore how to analyze and interpret your own single-cell RNA-seq (scRNA-seq) data using QIAGEN CLC Genomics Workbench and QIAGEN Ingenuity Pathway Analysis (IPA). In this 90-minute training, you’ll learn how to: • Start with FASTQ, cell matrix file and/or differential expression file for scRNA-seq data • Either automate or customize your analysis pipeline/workflow, depending on […]

  • Whole genome sequencing (WGS), rapid WGS and ultra-rapid WGS for hereditary disorders – where speed matters

    Virtual - Americas - EST , United States

    QIAGEN CLC LightSpeed Module delivers an ultra-fast, end-to-end hereditary NGS FASTQ to VCF pipeline. LightSpeed takes raw FASTQ files generated by paired-end 150 bp sequencing protocols and performs quality trimming, adapter trimming, read mapping, deduplication, local realignment, QC and germline variant calling. More details: https://qiagen.showpad.com/share/Tue4ZxKsjAFetyoswbTfE Cloud module: QIAGEN CLC Genomics Cloud computing software allows you […]

  • Checkpoint inhibitors in the context of biomarkers, drug targets and pathways

    Virtual - Americas - EST , United States

    In this training, we will focus on how you can use QIAGEN Omicsoft Studio and QIAGEN Ingenuity Pathway Analysis (IPA) to discover new biomarkers, validate (or study) drug targets and identify novel mechanisms of action with your own and/or public checkpoint inhibitor datasets from resources like GEO, SRA, TCGA and more. In this training, you’ll […]

  • How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting: Part 2

    Virtual - EMEA - CET

    We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18, 2023. The two-part, content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of […]

  • Pathway and network analysis on different types of lists with QIAGEN IPA

    Virtual - Americas - EST , United States

    You may not have a typical transcriptomics dataset (i.e., a list of genes with differential expression), yet, you’d like to analyze a list of IDs. In this training, we will explore how to perform pathway and network analysis for lists of IDs in QIAGEN IPA. Examples of lists that we’ll explore include: • A gene/protein/metabolite […]